Severity 2 of 5
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Severity 2 (Moderate) recalls cover minor labeling errors, low-risk contamination, and voluntary precautionary recalls. The agency's own classification is typically FDA Class III, or the issue is something like incomplete instructions or a small UPC mismatch where the product itself is safe but doesn't meet documentation requirements. Use the same brand-name product safely; follow the manufacturer's instructions for return or exchange if you want a refund.
The full rubric is on the methodology page. Severity is computed deterministically from the agency’s own classification plus the source text — no editorial vibes.
Aidapak Services, LLC is recalling Docusate Sodium capsules because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.
Novartis Consumer Health is recalling NeoCitran Extra Strength Cold & Flu powder packets because they may contain foreign substances.
Aidapak Services is recalling Valsartan 40 mg tablets because they may have been mislabeled as Valsartan 80 mg or Zinc Sulfate 50 mg.
Novartis Consumer Health is recalling Theraflu Severe Cold & Cough powder packets because they may contain foreign substances. The recall covers 917,400 cartons distributed in the US and internationally.
Aidapak Services, LLC is recalling Modafinil 200 mg tablets because they may have been mislabeled as Omega-3-Acid Ethyl Esters capsules.
Aidapak Services is recalling Efavirenz 600 mg tablets because they may have been mislabeled as Niacin ER 500 mg.
Aidapak Services is recalling Famciclovir 500 mg tablets because they may have been mislabeled as Tolterodine or Thiamine.
Aidapak Services, LLC is recalling prednisone 20 mg tablets that may have been mislabeled as methylprednisolone 4 mg.
Aidapak Services, LLC is recalling glyBURIDE tablets because they may have been mislabeled as CYPROHEPTADINE HCL or AMANTADINE HCL.
Aidapak Services is recalling 811 tablets of 20 mg Atorvastatin Calcium because they may be mislabeled as other drugs.
Aidapak Services, LLC is recalling Mesalamine DR capsules that may have been mislabeled as Chlorophyllin Copper Complex tablets.
Aidapak Services is recalling Oxybutynin Chloride tablets that may be mislabeled as Pimozide. The error could lead to patients receiving the wrong medication.
Aidapak Services, LLC is recalling Pyridoxine HCL 100 mg tablets because they may have been mislabeled as other drugs. The repacked drugs were distributed in four western states.
Aidapak Services is recalling 1,101 chlordiazepoxide capsules because they may have been mislabeled as other medications. The affected drugs were distributed in four western states.
Aidapak Services, LLC is recalling 40 mg atorvastatin calcium tablets that may have been mislabeled as 10 mg atorvastatin or 5 mg finasteride.
Aidapak Services is recalling Hyoscyamine Sulfate ODT tablets that may have been mislabeled as Fluoxetine HCl capsules.
Aidapak Services, LLC is recalling Calcium Carbonate/Cholecalciferol tablets because they may be mislabeled as Repaglinide. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Novartis Consumer Health is recalling Theraflu Sugar-Free Nighttime Severe Cold & Cough powder packets because they may contain foreign substances.
Greenstone LLC is recalling 585,096 bottles of sertraline HCl tablets because the expiration dates reflect a 36-month shelf life instead of the correct 24-month shelf life.
Aidapak Services, LLC is recalling Nabumetone 500 mg tablets that may have been mislabeled as guaiFENesin ER 600 mg. The FDA classifies this as a Class II recall.
Remel Inc is recalling Oxoid Norfloxacin 10 mcg antimicrobial susceptibility test discs because some cartridges may contain discs not impregnated with the antibiotic.
Aidapak Services is recalling Levothyroxine Sodium tablets that may have been mislabeled as Isoniazid due to a labeling error.
Aidapak Services, LLC is recalling Bumetanide 1 mg tablets that may have been mislabeled as Guaifenesin ER 600 mg. The error could lead to incorrect medication administration.
Aidapak Services, LLC is recalling RILUZOLE 50 mg tablets because they may have been mislabeled as LACTOBACILLUS 0 mg tablets.
Aidapak Services is recalling Valsartan 320 mg tablets because they may have been mislabeled as Cilostazol 100 mg.